SUSPENSION LETTER - MAILED
mailed
on 24 Sep 2024
Last Applicant/ Owned by
2-11-8 Shibadaimon
Minato-ku, Tokyo
JP
105-0012
Serial Number
97622009 filed on 06th Oct 2022
Registration Number
N/A
Correspondent Address
JAMES J. BOSCO, JR., REGISTRATION NO. 51,489
James J. Bosco, Jr., Registration No. 51,489 THE WEBB LAW FIRM
420 FORT DUQUESNE BOULEVARD, SUITE 1200
PITTSBURGH, PA 15222
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
MBL
Testing, analysis and evaluation for approval of goods and services of others to ensure compliance with industry standards; Research and development services in the field of pharmaceutical products; Research and development services in the field of antibodies; Laboratory research services in the field of pharmaceuticals using experimental animals; Cell culture services for scientific and research Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Testing, analysis and evaluation for approval of goods and services of others to ensure compliance with industry standards; Research and development services in the field of pharmaceutical products; Research and development services in the field of antibodies; Laboratory research services in the field of pharmaceuticals using experimental animals; Cell culture services for scientific and research purposes, for others; Stem cell research services; Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals, in vitro diagnostics, treatment or diagnostics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development support services, namely, pharmaceutical research and development; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Chemical reagents for medical purposes in the fields of cancer, cardiology, autoimmunity and immunological disorders, respiratory diseases, apoptosis, signal transduction, DNA, proteomics and genomics; Reagents for use in medical genetic testing; Immunoassay reagents for medical use; Diagnostic biomarker reagents for medical purposes; Companion diagnostics, namely, medical diagnostic reagents that assist in predicting the effects of a drug, the presence or absence of side effects, and the choice of patients to administer
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97622009
Mark Type
No Service Mark
Attorney Docket Number
No 1217-2206716
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Sep 2024 | SUSPENSION LETTER WRITTEN |
| 24th Sep 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 24th Sep 2024 | LETTER OF SUSPENSION E-MAILED |
| 12th Jul 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| 12th Jul 2024 | EX PARTE APPEAL-INSTITUTED |
| 12th Jul 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| 12th Jul 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 12th Apr 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 12th Apr 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 20th Feb 2024 | ASSIGNED TO EXAMINER |